Main > PNEUMOLOGY > Common Cold > Treatment > RhinoVirus Protease Inhibitors > AG7088 Experimental Drug > Mechanism of Action

Product USA. A

MECHANISM OF ACTION AG7088 ATTACKS RHINOVIRUS 3C PROTEASE
The 3C protease (3CP) enzyme is central to rhinovirus replication. By binding to and inhibiting this enzyme, AG7088 prevents rhinovirus replication in cells of the respiratory tract and stops cold symptoms developing. The drug appears effective against many rhinovirus strains suggesting broad-spectrum anti-viral activity
UPDATE 05.03
COMPANY This data is not available for free

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back